These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16447341)

  • 1. The Trading with the Enemy Act of 1917 and synthetic drugs: relieving scarcity, controlling prices, and establishing pre-market licensing controls.
    Cooper D
    Pharm Hist; 2005; 47(2):47-61. PubMed ID: 16447341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The licensing of German drug patents confiscated during World War I: federal and private efforts to maintain control, promote production, and protect public health.
    Cooper D
    Pharm Hist; 2012; 54(1):3-32. PubMed ID: 24620480
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationships between the academic community and the pharmaceutical industry: the legislative background and its effect on spending on medical research and development.
    Matthews JH
    Clin Invest Med; 1996 Dec; 19(6):470-8. PubMed ID: 8959357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prices of pharmaceutical preparations in Denmark until 1645: a study of the legislation for stipulating the consumer price of drugs].
    Kruse PR
    Theriaca; 1991 Oct; 27():3-315. PubMed ID: 11640853
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceuticals: pharmaceutical cost controls--2005. End of Year Issue Brief.
    Seay M; Varma P
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Who's winning the human race?"Cold war as pharmaceutical political strategy.
    Tobbell DA
    J Hist Med Allied Sci; 2009 Oct; 64(4):429-73. PubMed ID: 19493917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using market-exclusivity incentives to promote pharmaceutical innovation.
    Kesselheim AS
    N Engl J Med; 2010 Nov; 363(19):1855-62. PubMed ID: 21047231
    [No Abstract]   [Full Text] [Related]  

  • 8. The Affordable Prescription Drugs Act: a solution for today's high prescription drug prices.
    Pinzone JD
    J Law Health; 2001-2002; 16(1):145-68. PubMed ID: 14650775
    [No Abstract]   [Full Text] [Related]  

  • 9. America's first drug regulation regime: the rise and fall of the Import Drug Act of 1848.
    Heath WJ
    Food Drug Law J; 2004; 59(1):169-99. PubMed ID: 15212037
    [No Abstract]   [Full Text] [Related]  

  • 10. Sublicense or supply agreement? Supreme Court of Canada interpretation benefits generic pharmaceutical industry.
    Burshtein S
    Food Drug Law J; 1999; 54(1):73-91. PubMed ID: 11758562
    [No Abstract]   [Full Text] [Related]  

  • 11. How can states provide affordable pharmaceuticals to the underserved?
    Zara J
    J Health Care Poor Underserved; 2006 Nov; 17(4):808-20. PubMed ID: 17242532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmaceutical patents and the accessibility of drugs in Brazil].
    Marques MB
    Hist Cienc Saude Manguinhos; 2000; 7(1):7-21. PubMed ID: 11625765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of the Hatch-Waxman Act and its impact on the drug development process.
    Mossinghoff GJ
    Food Drug Law J; 1999; 54(2):187-94. PubMed ID: 11758572
    [No Abstract]   [Full Text] [Related]  

  • 14. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Realizing two-tiered innovation policy through drug regulation.
    Ridgway WE
    Stanford Law Rev; 2006 Feb; 58(4):1221-50. PubMed ID: 16685807
    [No Abstract]   [Full Text] [Related]  

  • 16. Should the patent system for new medicines be abolished?
    DiMasi JA; Grabowski HG
    Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
    [No Abstract]   [Full Text] [Related]  

  • 17. Opinion: The high cost of low drug prices.
    Franks B
    N J Med; 2004; 101(7-8):56, 55. PubMed ID: 15373148
    [No Abstract]   [Full Text] [Related]  

  • 18. [Patents in the pharmaceutical field: history and development of the institution].
    Neri M
    Boll Chim Farm; 1995; 134(7):364-8. PubMed ID: 7546541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical price review in Canada.
    Eastman HC
    Pharmacoeconomics; 1994 Apr; 5(4):278-85. PubMed ID: 10147237
    [No Abstract]   [Full Text] [Related]  

  • 20. Patents for critical pharmaceuticals: the AZT case.
    Ackiron E
    Am J Law Med; 1991; 17(1-2):145-80. PubMed ID: 1877607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.